Detalles de la búsqueda
1.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Breast Cancer Res Treat
; 168(2): 389-399, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29230663
2.
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 16(4): 436-46, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795409
3.
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients.
BMC Cancer
; 13: 232, 2013 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23659317
4.
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
BMC Cancer
; 13: 42, 2013 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-23368410
5.
Colorectal cancer mouse metastasis model combining bioluminescent and micro-computed tomography imaging for monitoring the effects of 5-fluorouracil treatment.
Transl Cancer Res
; 12(10): 2572-2581, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969373
6.
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.
Cancer Commun (Lond)
; 43(9): 1003-1026, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434394
7.
Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial.
NPJ Breast Cancer
; 8(1): 110, 2022 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127351
8.
miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Cytokine
; 56(3): 589-92, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21907588
9.
Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
Mol Biol Rep
; 38(4): 2295-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21052845
10.
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Breast Cancer Res Treat
; 123(2): 549-55, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20143151
11.
Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat
; 124(2): 419-24, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20300826
12.
Maintenance chemotherapy is effective in patients with metastatic triple negative breast cancer after first-line platinum-based chemotherapy.
Ann Palliat Med
; 9(5): 3018-3027, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787354
13.
[Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Zhonghua Zhong Liu Za Zhi
; 28(7): 523-5, 2006 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-17147118
14.
Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.
PLoS One
; 11(1): e0139782, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26766567
15.
The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
Med Oncol
; 32(11): 254, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26487662
16.
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.
J Exp Clin Cancer Res
; 34: 85, 2015 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26297142
17.
Gossypium barbadense genome sequence provides insight into the evolution of extra-long staple fiber and specialized metabolites.
Sci Rep
; 5: 14139, 2015 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420475
18.
The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.
Clin Nucl Med
; 38(4): 256-62, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23429396
19.
Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
Cancer Chemother Pharmacol
; 71(1): 103-13, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053266
20.
Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients.
Med Oncol
; 29(2): 418-24, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21298496